Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Cerilliant
Queensland Health
Accenture
Harvard Business School
Fish and Richardson
US Department of Justice
US Army
Novartis
UBS

Generated: January 22, 2018

DrugPatentWatch Database Preview

FELDENE Drug Profile

« Back to Dashboard

When do Feldene patents expire, and what generic alternatives are available?

Feldene is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in FELDENE is piroxicam. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the piroxicam profile page.

US Patents and Regulatory Information for FELDENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for FELDENE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982 ➤ Subscribe ➤ Subscribe
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982 ➤ Subscribe ➤ Subscribe
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Subscribe ➤ Subscribe
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Subscribe ➤ Subscribe
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Subscribe ➤ Subscribe
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982 ➤ Subscribe ➤ Subscribe
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982 ➤ Subscribe ➤ Subscribe
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Subscribe ➤ Subscribe
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Subscribe ➤ Subscribe
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Chubb
Colorcon
Deloitte
QuintilesIMS
Covington
Citi
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot